These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26335011)
1. Role of Amylase-α2A Autoantibodies in the Diagnosis of Autoimmune Pancreatitis. Sánchez Castañón M; Zuliani V; Amodio A; Campagnola P; Granato A; Gabbrielli A; Benini L; López Hoyos M; Frulloni L Pancreas; 2015 Oct; 44(7):1078-82. PubMed ID: 26335011 [TBL] [Abstract][Full Text] [Related]
2. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis. Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335 [TBL] [Abstract][Full Text] [Related]
3. Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis. Ngwa T; Law R; Hart P; Smyrk TC; Chari ST Pancreas; 2015 May; 44(4):557-60. PubMed ID: 25785724 [TBL] [Abstract][Full Text] [Related]
4. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306 [TBL] [Abstract][Full Text] [Related]
5. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Song TJ; Kim MH; Moon SH; Eum JB; Park DH; Lee SS; Seo DW; Lee SK Am J Gastroenterol; 2010 Jul; 105(7):1655-60. PubMed ID: 20010924 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel antibody associated with autoimmune pancreatitis. Frulloni L; Lunardi C; Simone R; Dolcino M; Scattolini C; Falconi M; Benini L; Vantini I; Corrocher R; Puccetti A N Engl J Med; 2009 Nov; 361(22):2135-42. PubMed ID: 19940298 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of autoimmune pancreatitis from pancreas cancer: utility of anti-amylase and anti-carbonic anhydrase II autoantibodies. Sánchez-Castañón M; de Las Heras-Castaño G; Gómez C; López-Hoyos M Auto Immun Highlights; 2012 Apr; 3(1):11-7. PubMed ID: 26000123 [TBL] [Abstract][Full Text] [Related]
8. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025 [TBL] [Abstract][Full Text] [Related]
9. [Clinical usefulness of serum immunoglobulin G and G4 level in the diagnosis of autoimmune pancreatitis]. Kang P; Lee KT; Sinn DH; Kim BJ; Lee JS; Lee JK; Rhee JC Korean J Gastroenterol; 2008 Nov; 52(5):304-9. PubMed ID: 19077477 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of B cell-activating factor in autoimmune pancreatitis. Yamanishi H; Kumagi T; Yokota T; Azemoto N; Koizumi M; Kobayashi Y; Abe M; Murakami H; Hiasa Y; Matsuura B; Kawamoto H; Yamamoto K; Onji M Pancreas; 2011 Aug; 40(6):840-5. PubMed ID: 21747319 [TBL] [Abstract][Full Text] [Related]
13. Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer. Detlefsen S; de Vos JD; Tanassi JT; Heegaard NHH; Fristrup C; Schaffalitzky de Muckadell OB Medicine (Baltimore); 2018 Aug; 97(31):e11641. PubMed ID: 30075546 [TBL] [Abstract][Full Text] [Related]
14. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody. Hosoda H; Okawa-Takatsuji M; Shinmura W; Hasimoto N; Ozaki Y; Ikeda Y Pancreas; 2008 Jul; 37(1):e1-7. PubMed ID: 18580434 [TBL] [Abstract][Full Text] [Related]
15. Potential value of serum total IgE for differentiation between autoimmune pancreatitis and pancreatic cancer. van Toorenenbergen AW; van Heerde MJ; van Buuren HR Scand J Immunol; 2010 Nov; 72(5):444-8. PubMed ID: 21039739 [TBL] [Abstract][Full Text] [Related]
16. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma. Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701 [TBL] [Abstract][Full Text] [Related]
17. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels. Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441 [TBL] [Abstract][Full Text] [Related]
18. Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer. Hao M; Li W; Yi L; Yu S; Fan G; Lu T; Yang X; Wang G; Zhang D; Ding J; Zhang K; Zhang R; Lin G; Han Y; Wang L; Li J Sci Rep; 2016 Jun; 6():27415. PubMed ID: 27271825 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of autoimmune pancreatitis. Matsubayashi H; Kakushima N; Takizawa K; Tanaka M; Imai K; Hotta K; Ono H World J Gastroenterol; 2014 Nov; 20(44):16559-69. PubMed ID: 25469024 [TBL] [Abstract][Full Text] [Related]
20. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]